An Open label, Randomized, Controlled study to assess the efficacy of Olmesartan and Chlortalidone on Arterial Stiffness In Patients With Newly Diagnosed Essential Hypertension.

Trial Profile

An Open label, Randomized, Controlled study to assess the efficacy of Olmesartan and Chlortalidone on Arterial Stiffness In Patients With Newly Diagnosed Essential Hypertension.

Completed
Phase of Trial: Phase II

Latest Information Update: 04 Aug 2015

At a glance

  • Drugs Olmesartan medoxomil (Primary) ; Chlortalidone
  • Indications Essential hypertension
  • Focus Therapeutic Use
  • Most Recent Events

    • 04 Aug 2015 New trial record
    • 15 Jun 2015 Results presented at the 25th European Meeting on Hypertension and Cardiovascular Protection.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top